Solid Biosciences Inc. · NASDAQ:SLDB
Vestal Point Capital, LP's stake in Solid Biosciences Inc. fell to 2.30% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Vestal Point Capital, LP's stake in Solid Biosciences Inc. fell to 2.30%, 1,753,558 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 2.30%
- Shares
- 1,753,558
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 2.30% | 1,753,558 |
| Ryan Wilder | 2.30% | 1,753,558 |
Source
Related
- Solid Biosciences Inc.
- Vestal Point Capital, LP
- Solid Biosciences Inc. shareholders
- Schedule 13G/A · Vestal Point Capital, LP · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Feb 17, 2026
- Form 4 · Brooks Gabriel · Oct 20, 2026
- Form 4 · Smith Ian F · Oct 6, 2026
- Schedule 13D/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G · FMR LLC · Aug 6, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026